Electra Therapeutics
Electra Therapeutics
electra-therapeutics.com
Locations
San Francisco, CA, USA · South San Francisco, CA, USA
industry
Biotechnology · Health Care · Medical
Size
11 - 50 employees
Stage
Series C
founded in
2018
About

Electra Therapeutics focuses on developing therapies that target the Signal Regulatory Protein (SIRP) family of receptors on immune cells. The company's portfolio of SIRP-directed antibodies is designed to address the underlying pathology across a range of diseases by selectively depleting pathological immune cells. The lead product candidate, ELA026, is a monoclonal antibody currently in pivotal clinical development for the treatment of secondary hemophagocytic lymphohistiocytosis (sHLH), a severe hyperinflammatory condition. Electra Therapeutics is also advancing a second program, ELA822, for use in immunology and inflammation conditions.

Something looks off?
Open jobs at Electra Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.